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Objectives: To analyse the role of growth factors (platelet derived growth factor, PDGF; basic fibroblast growth factor, 
bFGF; interleukin 1, IL-1) in the genesis of myointimal hyperplasia in arterial allografts. 
Materials: Two groups of experiments were performed: isografts and allografls. The isograft group consisted of 15 inbred 
Lewis rats in which a i cm long segment of aorta was inserted as an abdominal aortic interposition graft. The aortic 
segments were obtained from syngenic Lewis rats. The allograft group consisted of 15 inbred Lewis rats, in which a I cm 
long segment of aorta was interposed at the abdominal orta level. The aortic segments were obtained from alIogenic Brown- 
Norway rats. 
Chief outcome measures: The animals were killed 4 weeks after surgery and were analysed by morphometric analysis 
(n = 3for each group). In addition, production of PDGF, bFGF and IL-1 by aortic segments (n = 12for each group) in organ 
culture was assessed. 
Main results: Allografts had more myointimal hyperplasia, than isografts (p < 0.05). PDGF and bFGF production, 
generally considered to be the cause of myointimal hyperplasia, was not increased in allografts. IL-1 production was higher 
in allografts (p < 0.001). 
Main conclusions: Myointimal hyperplasia n aortic allografts is dependent on growth factors produced by the graft itself. 
These growth factors are different from PDGF and bFGF that generally have been implicated in the genesis of naturally 
occurring myointimal hyperplasia nd atherosclerosis. IL-1 may have a principal role in the genesis of myointimal 
hyperplasia in arterial allografts. 
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Introduction 
The autogenous aphenous vein is the conduit of 
choice for small artery bypass surgery. However, it is 
not always available. Theoretically, arterial allografts 
could represent a valid alternative. The use and 
complications that occur in allografts were first 
described by Carell I and Guthrie 2and several studies 
have defined the response of transplanted arterial 
allografts. 3~s 
The pathologic changes are either graft dilatation 
and rupture caused by media destruction or a narrow- 
ing of the graft lumen caused by myointimal cell 
proliferation, which may lead to arterial occlusion. 
The factors leading to myointimal hyperplasia in 
*Please address all correspondence to: Antonio V. Sterpetti, Labo- 
ratorio Castro Laurenziano-I Clinica Chirurgica, University of 
Rome, Via A. Scarpa, 14, 00161 Rome, Italy. 
arterial allografts are unknown. Growth factors induce 
and regulate numerous cell functions during the 
process of myointimal hyperplasia nd atheroscler- 
osis. They may act in cell recruitment and migration, 
cell proliferation and the control of protein synthesis, 
including extracellular matrix proteins. Platelet 
derived growth factor (PDGF) and basic fibroblast 
growth factor (bFGF) are two of the best characterised 
mitogens for endothelial cells and smooth muscle 
9- 11 cells. - Several reports have demonstrated increased 
expression of PDGF and bFGF in association with 
naturally occurring atherosclerosis, experimentally 
induced atherosclerosis and stenoses associated with 
failure of autologous and synthetic vascular 
grafts. ~2-14 
The aim of this study was to determine if PDGF and 
bFGF were also responsible for myointimal hyper- 
plasia occurring in arterial allografts, and if other 
factors were also involved. 
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Material and Methods 
Operative procedures 
Fifteen Brown-Norway rats and 45 Lewis rats (average 
weight 250 g) were used for the experiments. These 
inbred strains were chosen because of their immuno- 
logic histoincompatibility. Experiments were per- 
formed in two groups of 30 rats (15 donors, 15 
recipients). In the autograft, Lewis rats were both 
donors and recipients. In the allograft group, the 
donors were Brown-Norway rats and the recipients 
were Lewis rats. 
All surgery was performed under general anaes- 
thesia with intramuscular Xylazine (3 mg/kg) and 
Ketamine (50mg/kg) supplemented by intraperito- 
neal Ketamine for maintenance. Surgery was per- 
formed with the use of an operating microscope (Zeiss 
OPMI-7D). A midline laparotomy was performed on 
the donor and the aorta was exposed from the renal 
arteries to the bifurcation. The exposed aortic segment 
was then excised and placed in Dulbecco Modified 
Eagle Medium (DMEM) for approximately 20 min 
while the abdominal aorta of the recipient was 
exposed and proximal and distal controls obtained. 
One centimetre long segments of the previously 
harvested graft were anastomosed with end-to-end 
anastomoses to the native aorta, with continuous 10-0 
nylon sutures (Ethicon Inc.). Four weeks after surger~ 
the rats were killed and the aortas, above and below 
the graft, and the aortic grafts were exposed and 
excised. No immunosuppression was used in these 
experiments. 
Histology (n = 3 for each group) 
Grafts were perfusion fixed with Hanks' solution and 
10% formaldehyde. Following standard procedures, 
the specimens were stained with haematoxylin and 
eosin, giemsa and carmallum. Transverse and sagittal 
sections were cut for each graft and from the native 
aorta at different levels. Slides were analysed in a 
semi-automatic mage processor to measure intima~ 
media area. 
200 ~g/ml, Streptomycin 100 ~g/ml, Penicillin 100 IU/ 
ml). The vessels were opened longitudinally and 
placed in organ cultures. The specimens were placed 
in 48-well Costar tissue culture plates for organ 
culture. The tissue was incubated for 5 days at 37°C in 
a 5% CO2 atmosphere. Aliquots of conditioned media 
were collected at 72 h and centrifuged for 5 min at 
15 000 rpm and the supernatant was stored at -80°C 
for assay of mitogenic activity and assay for PDGF, 
bFGF and interleukin 1 (IL-1) production. 
Assay for mitogenic activity 
Swiss 3T3 cells were placed in 96 well plates (Falcon 
Plastics) at a density of 4 × 104 cells/ml in 200 ~1 of 
DMEM supplemented with 0.1% foetal calf serum 
(FCS). At 72 h, conditioned serum-free media from 
aortic allo- and isografts, and aortic segments were 
added to Swiss 3T3 cells (20~1). Positive controls 
received an equivalent volume of DMEM plus human 
recombinant bFGF (20 ng/ml) or human recombinant 
PDGF (50 ng/ml) (Genzyme Co, Boston, MA, U.S.A.); 
negative controls received only DMEM. After 2 days, 
trifiated thymidine (0.5 ~t Ci per well plate) was added 
and the cultures were incubated for 18 h and collected 
on Skatron Filters (Skatron Instruments; Sterling, VA, 
U.S.A.) for radioactivity determination in a LKB 
scintillation counter. 
Analysis of reduction of mitogenic activity by anti-PDGF 
and anti-bFGF antibody 
Measurement of the Swiss 3T3 cells DNA synthesis- 
stimulating activity of the conditioned media from 
aortic allo- and isografts was repeated in presence of 
an excess of monospecific antibody to PDGF (Gen- 
zyme) and in the presence of monoclonal antibody to 
bFGF (produced in our laboratory). Tritiated thymi- 
dine was again added and the cultures were incubated 
for 18 h. After further processing the radioactivity was 
measured. 
Organ culture(n= 12) 
The aortic iso- and allografts and the control aortic 
segments were rinsed thoroughly for 10 min with 
DMEM supplemented with antibiotics (Gentamycin 
Assay of PDGF, bFGF and IL-1 in the conditioned media 
The presence of bFGF, PDGF and IL-1 in the serum- 
free conditioned media from aortic allo- and isografts, 
and aortic segments was determined by inhibition 
antibody-binding assay. A dilution of anti-bFGF 
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monoclonal antibody that showed 50% maximal reac- 
tivity against bFGF (4~g/ml) was incubated with 
various dilutions of conditioned media in 400 ~1 tubes 
precoated with phosphate buffered saline (PBS) 
gelatin 2%. After 20 h of incubation at 4°C, Staphylococ- 
cus aureus protein A was added, and the immunoag- 
gregates were removed by centrifugation. The resid- 
ual antibody-binding activity in the supernatant was 
measured by ELISA, according to a method already 
described. 15In brief, plastic wells were coated with 
bFGF (10ng/well) for 8 h at 4°C. Plates were then 
washed twice with PBS and saturated with PBS- 
gelatin 1% for 2 h at 37°C. Washed wells were then 
filled with 50 ~1 per well of supernatant obtained after 
immunoprecipitation. After 2 h of incubation at 37°C 
the wells were washed with PBS gelatin 0.1%. Perox- 
idase labeled goat anti-mouse immunoglobulin anti- 
body was added. After 60 rain of incubation at 37°C, 
the plate was washed three times in PBS gelatin 0.1% 
and once in distilled water. Finally, O-phenylenedia- 
mine dihydrochloride (0.4mg/ml)(Sigma, St. Louis, 
MO, U.S.A.) was added as substrate for the enzyme. 
Bound specific antibody was quantitatively measured 
by optical density reading at 492nm with a spec- 
trophotometer (Beckman Instruments, Inc., Palo Alto, 
CA, U.S.A.). The amount of bFGF in the conditioned 
media was determined by using a reference curve 
obtained by using known quantities of human recom- 
binant bFGF. We used mouse anti-bFGF monoclonal 
antibody as a positive control and antibody without 
specificity as a negative control. Similar experiments 
were used to determine the presence and amount of 
PDGF and IL-1 in the conditioned media, with rabbit 
polyclonal antibody to PDGF (Genzyme) and mouse 
monoclonal antibody to IL-1 (Genzyme) respectively. 
Statistical analysis 
Chi-squared test, analysis of variance and Student's 
t-test were used where appropriate. Data were 
expressed as mean + S.D. Differences were considered 
significant at the 5% level. 
hyperplasia. There were signs of rejection in aortic 
allografts, with diffuse cellular infiltration in the 
adventitia, medial thinning and intimal proliferation. 
The intima-media area was statistically greater in the 
aortic allografts (p < 0.05) (Fig. 1) (Table 1). 
Mitogenic activity of the conditioned media and the effect 
of anti-PDGF and anti-bFGF 
There was a statistically higher mitogenic activity in 
the conditioned media from aortic allografts than in 
the conditioned media from isografts (Fig. 2) 
(p < 0.001). The addition of serum-free conditioned 
media from allografts produced a three-fold mean 
increase of tritiated thymidine uptake of Swiss 3T3 cell 
cultures as compared with conditioned media from 
isografts. This increased production of mitogens could 
stimulate the growth of smooth muscle cells and lead 
to myointimal hyperplasia and atherosclerosis. Reduc- 
tion of mitogenic activity by anti-PDGF and anti-bFGF 
antibodies means that the mitogenic activity is due to 
these particular growth factors. The addition of 
monospecific anti-PDGF antibody to the medium of 
3T3 cell cultures exposed to conditioned medium from 
allografts had a negligible effect on the uptake of 
tritiated thymidine (Fig. 3). Similarly, the addition of 
monospecific anti-bFGF antibody to the medium of 
3T3 cell cultures exposed to conditioned medium from 
allografts had a negligible effect on the uptake of 
tritiated thymidine (Fig. 4). 
PDGF, bFGF and IL-1 assay by ELISA 
Table 2 shows the release of PDGF, bFGF and IL-1 by 
aortic allo- and isografts. The release of PDGF and 
bFGF paradoxically was increased in aortic isografts 
(p <0.01). IL-1 production was higher in allografts 
than in isografts (p < 0.001). 
Results 
All grafts were patent at the time of death. 
Histology 
Aortic isografts howed minor degree of myointimal 
Discussion 
Accelerated graft myointimal hyperplasia and athero- 
sclerosis are the main factors that limit the success of 
cardiac and renal transplantation. 16-2° In peripheral 
vascular surger)5 the use of arterial allografts has 
shown a sequence of pathologic events Consisting in 
thinning of the media, dislocation of elastic laminae, 
invasion of the adventitia by inflammatory cells and 
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intimal hyperplasia. 7's The factors leading to intimal 
hyperplasia re probably secondary to an immuno- 
logic process. In our study we tried to determine if the 
myointimal hyperplasia seen in aortic allografts was 
caused by an increased production of PDGF and bFGF. 
Many studies support a role for PDGF and bFGF in 
the genesis of myointimal hyperplasia nd athero- 
sclerosis, Birinyi et al. 14 cultured cells from myointimal 
hyperplasia obtained from patients at the time of re- 
exploration for lower extremity graft failure. They 
found that cultured smooth muscle cells from myoin- 
timal hyperplasia express genes for PDGF and PDGF 
receptors. 
Several other reports have demonstrated increased 
expression of PDGF and bFGF with naturally occur- 
ring myointimal hyperplasia and atherosclerosis, 
(a) 
(b) 
Fig. 1. Light microscopy of aortic isograft (a) and allograft (b). Aortic isografts appeared normal whereas aortic allografts showed signs of 
rejection, with diffuse cellular infiltration in the adventitia, medial thinning and int mal proliferation. The intima-media area was 
statistically greater in the aortic allografts. L = Lumen; MH = myointimal hyperplas a. 
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Table 1. Intima-media area. 
Area infima + media (~tm 2 x 10 s) 
Normal aorta 2.74 _+ 0.2 
Isograf~ 3.11 _+ 0.3 
Allograft 4.00 + 0.2 
Each value represents he mean + S.D, of three separate xperiments. 
experimentally induced atherosclerosis, and stenoses 
associated with failure of vascu la r  grafts. 13'14'16 The 
principal animal model that has been used to study 
myointimal hyperplasia is balloon angioplasty of the 
normal carotid artery. Jawien et aI. 21 found that PDGF 
infused into rats subjected to balloon carotid injury 
produced a two- to three-fold increase in medial 
smooth muscle cell proliferation, and a 20-fold 
increase in migration of smooth muscle cells from the 
media to the intima. Administration of antibodies to 
PDGF resulted in a 40% reduction in area of myointi- 
mal hyperplasia. 22Similarly, it has been shown that 
16 000 
administration of antibodies to bFGF significantly 
reduced smooth muscle cell proliferation after balloon 
injury. 2s 
In our study we found that aortic allografts release 
a greater quantity of mitogens than aortic isografts. 
This phenomenon could represent the cause for the 
occurrence of myointimal hyperplasia nd athero- 
sclerotic hanges in arterial allografts. 4 The source of 
these growth factors can be only speculative. Results 
from our and other laboratories have shown that CD4 
and CD8 lymphoid cells infiltrate the adventitia nd 
the intima of aortic allografts (S. Lepidi, unpublished 
data). These cells could produce many growth factors 
including IL-1, IL-2 and GM-CSF. From our study it is 
evident hat PDGF and bFGF are not implicated in the 
genesis of myointimal hyperplasia in aortic allografts 
and that other growth factors are involved including 
IL-1. 
The results of our experiments demonstrate hat the 
mechanisms leading to myointimal hyperplasia nd 
probably atherosclerosis in aortic aUografts are differ- 
ent from the pathogenesis of naturally occurring 
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Fig. 2. The addition of serum-free conditioned media from allografts 
produced a three-fold mean increase of tritiated thymidine uptake 
of Swiss 3T3 cell cultures as compared with conditioned media from 
isograffs. 
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Fig. 3, The addition of monospecific anti-PDGF antibody to the 
medium of 3T3 cell cultures exposed to conditioned medium from 
aUografts had a negligible effect on the uptake of tritiated 
thymidine. (B) without anti-PDGF; (71) with anti-PDGF. 
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Fig. 4. The addition of monospecific anti-bFGF antibody to the 
medium of 3T3 cell cultures exposed to conditioned medium from 
allografts had a negligible effect on the uptake of tritiated 
thymidine. ( , )  without anti-bFGF; ([~) with anti-bFGF. 
Table 2. Release of bFGF, PDGF and IL-1 (ng/cm2/72 h). 
bFGF PDGF IL-1 
Isograft 79 _+ 6 39 ± 7 0.3 _+ 0.04 
Allograft 25 _+ 3 15 ± 5 1.1 + 0.13 
Thoracic aorta 46 + 8 32 ± 8 0.17 + 0.02 
Each value represents he mean ± S.D. of 12 separate xperiments. 
atherosclerosis. Further research is needed to identify 
these growth factors. 
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